Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Diabetologia. 2013 Aug 10;56(11):10.1007/s00125-013-3009-7. doi: 10.1007/s00125-013-3009-7

Fig. 4.

Fig. 4

Effect of systemic B2AR agonist on recovery from hypoglycaemia. Plasma concentrations of glucose (a), glucagon (b), adrenaline (c) and noradrenaline (d) in rats receiving peripheral injection of the vehicle (control; n=4) and the B2AR agonist formoterol (n=4) during the recovery from hypoglycaemia. The arrow indicates the time at which the B2AR agonist was delivered. Circles and grey bars, B2AR agonist; squares and white bars, control. Results are presented as means ± SEM. *p<0.05 vs control